4.8 Article

AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3

Journal

AUTOPHAGY
Volume 17, Issue 12, Pages 3957-3975

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/15548627.2021.1898748

Keywords

AMP-activated protein kinase; autophagy; drug resistance; lysosomal biogenesis; mechanistic target of rapamycin kinase; phosphorylation; transcription factor EB; transcription factor E3

Categories

Funding

  1. Canadian Institutes of Health Research [PJT-165829]
  2. Cancer Research Society
  3. Kidney Foundation of Canada (KFOC) [KFOC100021]
  4. Terry Fox Research Institute [TFF-166128]

Ask authors/readers for more resources

It has been shown that AMPK regulates the transcriptional activity of TFEB and TFE3 through phosphorylation, with a significant impact during nutrient deprivation, FLCN depletion, and pharmacological manipulation of MTORC1 or AMPK. MTORC1 specifically controls the cytosolic retention of TFEB and TFE3, while AMPK is essential for their transcriptional activity. This dual and opposing regulation mechanism is reminiscent of the regulation of ULK1, another key regulator of autophagy.
Increased macroautophagy/autophagy and lysosomal activity promote tumor growth, survival and chemo-resistance. During acute starvation, autophagy is rapidly engaged by AMPK (AMP-activated protein kinase) activation and MTOR (mechanistic target of rapamycin kinase) complex 1 (MTORC1) inhibition to maintain energy homeostasis and cell survival. TFEB (transcription factor E3) and TFE3 (transcription factor binding to IGHM enhancer 3) are master transcriptional regulators of autophagy and lysosomal activity and their cytoplasm/nuclear shuttling is controlled by MTORC1-dependent multisite phosphorylation. However, it is not known whether and how the transcriptional activity of TFEB or TFE3 is regulated. We show that AMPK mediates phosphorylation of TFEB and TFE3 on three serine residues, leading to TFEB and TFE3 transcriptional activity upon nutrient starvation, FLCN (folliculin) depletion and pharmacological manipulation of MTORC1 or AMPK. Collectively, we show that MTORC1 specifically controls TFEB and TFE3 cytosolic retention, whereas AMPK is essential for TFEB and TFE3 transcriptional activity. This dual and opposing regulation of TFEB and TFE3 by MTORC1 and AMPK is reminiscent of the regulation of another critical regulator of autophagy, ULK1 (unc-51 like autophagy activating kinase 1). Surprisingly, we show that chemoresistance is mediated by AMPK-dependent activation of TFEB, which is abolished by pharmacological inhibition of AMPK or mutation of serine 466, 467 and 469 to alanine residues within TFEB. Altogether, we show that AMPK is a key regulator of TFEB and TFE3 transcriptional activity, and we validate AMPK as a promising target in cancer therapy to evade chemotherapeutic resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available